The therapeutic potential of GLP-1 receptor biased agonism. (2022)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.15497
PubMed Identifier: 33880754
Publication URI: http://europepmc.org/abstract/MED/33880754
Type: Journal Article/Review
Volume: 179
Parent Publication: British journal of pharmacology
Issue: 4
ISSN: 0007-1188